These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13865946)

  • 1. Clinical trial of a new hypotensive drug, methyldopa ("aldomet").
    BAUMGARTEN A
    Med J Aust; 1962 Jul; 49(2)():52-5. PubMed ID: 13865946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary report on the clinical effectiveness of 1-alpha-methyl-DOPA (Aldomet) in the treatment of hypertension].
    FELLINGER K; GRABNER G; KRYGICZ H
    Wien Z Inn Med; 1961 Dec; 42():527-30. PubMed ID: 13892223
    [No Abstract]   [Full Text] [Related]  

  • 3. Another hypotensive agent--methyldopa.
    DALEY D; EVANS B
    Br Med J; 1962 Jul; 2(5298):156-8. PubMed ID: 13883201
    [No Abstract]   [Full Text] [Related]  

  • 4. [Methyl-dopa (Aldomet), a new principle in the treatment of high blood pressure].
    MATHISEN HS
    Tidsskr Nor Laegeforen; 1962 Mar; 82():353-5. PubMed ID: 14471146
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension.
    ONESTI G; BREST AN; NOVACK P; MOYER JH
    Am J Cardiol; 1962 Jun; 9():863-7. PubMed ID: 14482028
    [No Abstract]   [Full Text] [Related]  

  • 6. Methyldopa in the treatment of hypertension.
    BAYLISS RI; HARVEY-SMITH EA
    Lancet; 1962 Apr; 1(7233):763-8. PubMed ID: 13866047
    [No Abstract]   [Full Text] [Related]  

  • 7. Methyldopa in hypertension. Clinical and pharmacological studies.
    DOLLERY CT; HARINGTON M
    Lancet; 1962 Apr; 1(7233):759-63. PubMed ID: 13887051
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha methyl dopa in the treatment of hypertension.
    DOYLE A; TREVAKS G
    Med J Aust; 1962 Jul; 49(2)():55-6. PubMed ID: 13887654
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alpha-Methyl-DOPA (Aldomet) in the therapy of arterial hypertension].
    JIMENEZ DIAZ C; DE LA BARREDA P; ORTEGA MATA R
    Rev Clin Esp; 1962 Oct; 87():80-6. PubMed ID: 13964653
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of alpha-methyl-dopa for the treatment of chronic hypertension].
    ARNOLD OH
    Dtsch Med Wochenschr; 1962 Apr; 87():844-8. PubMed ID: 13862447
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
    GILLESPIE L; OATES JA; CROUT JR; SJOERDSMA A
    Circulation; 1962 Feb; 25():281-91. PubMed ID: 13898638
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of alpha-methyl DOPA in severe and malignant hypertension.
    CANNON PJ; WHITLOCK RT; MORRIS RC; ANGERS M; LARAGH JH
    JAMA; 1962 Mar; 179():673-81. PubMed ID: 13876240
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopa.
    KIRKENDALL WM; WILSON WR
    Am J Cardiol; 1962 Jan; 9():107-15. PubMed ID: 14456308
    [No Abstract]   [Full Text] [Related]  

  • 14. CLINICAL STUDIES WITH METHYL-DOPA (ALDOMET) IN PATIENTS WITH HYPERTENSION DURING TWO YEARS.
    MATHISEN HS
    Acta Med Scand; 1963 Aug; 174():183-92. PubMed ID: 14051135
    [No Abstract]   [Full Text] [Related]  

  • 15. [alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action].
    SCHAUB F; NAGER F; SCHAER H; ZIEGLER W; LICHTLEN P
    Schweiz Med Wochenschr; 1962 May; 92():620-8. PubMed ID: 14498080
    [No Abstract]   [Full Text] [Related]  

  • 16. Agranulocytosis caused by methyl dopa (Aldomet).
    HALLWRIGHT GP
    N Z Med J; 1961 Dec; 60():567-70. PubMed ID: 13903962
    [No Abstract]   [Full Text] [Related]  

  • 17. [CLINICAL EXPERIENCE WITH A NEW HYPOTENSIVE DRUG: ALPHA-METHYL-DOPA].
    SERVI M; CANTERA N
    Clin Ter; 1963 Jul; 26():158-69. PubMed ID: 14050042
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary report on trial of l-alpha-methyl dopa (Aldomet) in the treatment of hypertension.
    PAYNE RW; CLOSE JH; WHITSETT TL; GOGERTY JG
    J Okla State Med Assoc; 1961 Aug; 54():430-2. PubMed ID: 13733683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of serotonin formation by alpha-methyl-DOPA].
    WESTERMANN E; BALZER H; KNELL J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 234(3):194-205. PubMed ID: 13600388
    [No Abstract]   [Full Text] [Related]  

  • 20. [PHEOCHROMOCYTOMA AS A CAUSE OF CURABLE ARTERIAL HYPERTENSION. PRESENTATION OF A NEW CASE].
    RAPADOERRAZTI A; JIMENEZCASADO M; RODRIGUEZSANTOS A; NAVARRO V
    Rev Clin Esp; 1963 Aug; 90():247-51. PubMed ID: 14091050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.